{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:13:37Z","timestamp":1790806417366,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T00:00:00Z","timestamp":1562803200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T00:00:00Z","timestamp":1562803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12887-019-1613-5","type":"journal-article","created":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T13:14:11Z","timestamp":1562850851000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Clinical manifestations and anti-TNF alpha therapy of juvenile Beh\u00e7et\u2019s disease in Taiwan"],"prefix":"10.1186","volume":"19","author":[{"given":"Ya-Chiao","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Hsu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Tsan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Chieh","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Hui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyh-Hong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bor-Luen","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,11]]},"reference":[{"issue":"17","key":"1613_CR1","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","volume":"341","author":"T Sakane","year":"1999","unstructured":"Sakane T, et al. Beh\u00e7et's disease. N Engl J Med. 1999;341(17):1284\u201391.","journal-title":"N Engl J Med"},{"issue":"6","key":"1613_CR2","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.autrev.2017.12.006","volume":"17","author":"A Greco","year":"2018","unstructured":"Greco A, et al. Behcet\u2019s disease: new insights into pathophysiology, clinical features and treatment options. Autoimmun Rev. 2018;17(6):567\u201375.","journal-title":"Autoimmun Rev"},{"issue":"5","key":"1613_CR3","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/rheumatology\/38.5.457","volume":"38","author":"I Krause","year":"1999","unstructured":"Krause I, et al. Childhood Behcet\u2019s disease: clinical features and comparison with adult-onset disease. Rheumatology (Oxford). 1999;38(5):457\u201362.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"1613_CR4","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1136\/annrheumdis-2015-208491","volume":"75","author":"I Kon\u00e9-Paut","year":"2016","unstructured":"Kon\u00e9-Paut I, et al. Consensus classification criteria for paediatric Beh\u00e7et's disease from a prospective observational cohort: PEDBD. Ann Rheum Dis. 2016;75(6):958\u201364.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1613_CR5","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.semarthrit.2013.06.001","volume":"43","author":"LC See","year":"2013","unstructured":"See LC, et al. Sex- and age-specific incidence of autoimmune rheumatic diseases in the Chinese population: a Taiwan population-based study. Semin Arthritis Rheum. 2013;43(3):381\u20136.","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"1613_CR6","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.jaad.2007.10.452","volume":"58","author":"Y Karincaoglu","year":"2008","unstructured":"Karincaoglu Y, et al. Demographic and clinical properties of juvenile-onset Behcet\u2019s disease: A controlled multicenter study. J Am Acad Dermatol. 2008;58(4):579\u201384.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1613_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1136\/bjo.2007.137141","volume":"93","author":"GK Sungur","year":"2009","unstructured":"Sungur GK, et al. Clinical and demographic evaluation of Behcet disease among different paediatric age groups. Br J Ophthalmol. 2009;93(1):83\u20137.","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"1613_CR8","first-page":"808","volume":"77","author":"G Hatemi","year":"2018","unstructured":"Hatemi G, et al. 2018 Update of the EULAR recommendations for the management of Behcet's syndrome. Ann Rheum Dis. 2018;77(6):808\u201318.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1613_CR9","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.cgh.2014.08.042","volume":"13","author":"S Tanida","year":"2015","unstructured":"Tanida S, et al. Adalimumab for the treatment of Japanese patients with intestinal Behcet\u2019s disease. Clin Gastroenterol Hepatol. 2015;13(5):940\u20138 e3.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1613_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jaut.2015.06.005","volume":"62","author":"H Vallet","year":"2015","unstructured":"Vallet H, et al. Efficacy of anti-TNF alpha in severe and\/or refractory Behcet's disease: multicenter study of 124 patients. J Autoimmun. 2015;62:67\u201374.","journal-title":"J Autoimmun"},{"key":"1613_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nrrheum.2017.208","volume":"14","author":"H Yazici","year":"2018","unstructured":"Yazici H, et al. Beh\u00e7et syndrome: a contemporary view. Nat Rev Rheumatol. 2018;14:107.","journal-title":"Nat Rev Rheumatol"},{"issue":"12","key":"1613_CR12","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1093\/rheumatology\/keu266","volume":"53","author":"V Calvo-Rio","year":"2014","unstructured":"Calvo-Rio V, et al. Anti-TNF-alpha therapy in patients with refractory uveitis due to Behcet's disease: a 1-year follow-up study of 124 patients. Rheumatology (Oxford). 2014;53(12):2223\u201331.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"1613_CR13","doi-asserted-by":"publisher","first-page":"395","DOI":"10.5217\/ir.2017.15.3.395","volume":"15","author":"N Inoue","year":"2017","unstructured":"Inoue N, et al. Long-term safety and efficacy of adalimumab for intestinal Behcet's disease in the open label study following a phase 3 clinical trial. Intest Res. 2017;15(3):395\u2013401.","journal-title":"Intest Res"},{"issue":"4","key":"1613_CR14","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/art.11204","volume":"49","author":"FT Saulsbury","year":"2003","unstructured":"Saulsbury FT, Mann JA. Treatment with infliximab for a child with Behcet's disease. Arthritis Rheum. 2003;49(4):599\u2013600.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1613_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2177\/jsci.33.157","volume":"33","author":"U Kaneko","year":"2010","unstructured":"Kaneko U, et al. Two patients with childhood-onset Behcet's disease successfully treated by anti-tumor necrosis factor therapy. Nihon Rinsho Meneki Gakkai Kaishi. 2010;33(3):157\u201361.","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"issue":"12","key":"1613_CR16","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1007\/s00296-012-2628-5","volume":"33","author":"S Watanabe","year":"2013","unstructured":"Watanabe S, et al. A young girl with refractory intestinal Behcet's disease: a case report and review of literatures on pediatric cases who received an anti-tumor necrosis factor agent. Rheumatol Int. 2013;33(12):3105\u20138.","journal-title":"Rheumatol Int"},{"issue":"8","key":"1613_CR17","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1093\/rheumatology\/38.8.728","volume":"38","author":"BB Bhakta","year":"1999","unstructured":"Bhakta BB, et al. Behcet\u2019s disease: evaluation of a new instrument to measure clinical activity. Rheumatology (Oxford). 1999;38(8):728\u201333.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"1613_CR18","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.ophtha.2004.12.034","volume":"112","author":"RB Nussenblatt","year":"2005","unstructured":"Nussenblatt RB, et al. Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series. Ophthalmology. 2005;112(5):764\u201370.","journal-title":"Ophthalmology"},{"issue":"8697","key":"1613_CR19","first-page":"1078","volume":"335","author":"International Study Group for Beh\u00e7et\u2019s, D","year":"1990","unstructured":"International Study Group for Beh\u00e7et\u2019s, D. Criteria for diagnosis of Behcet\u2019s disease. Lancet. 1990;335(8697):1078\u201380.","journal-title":"Lancet"},{"issue":"3","key":"1613_CR20","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/jdv.12107","volume":"28","author":"International Team for the Revision of the International Criteria for Behcet\u2019s, D","year":"2014","unstructured":"International Team for the Revision of the International Criteria for Behcet\u2019s, D. The international criteria for Behcet's disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014;28(3):338\u201347.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Suppl 108(6)","key":"1613_CR21","first-page":"119","volume":"35","author":"ED Batu","year":"2017","unstructured":"Batu ED, et al. The performance of different classification criteria in paediatric Behcet\u2019s disease. Clin Exp Rheumatol. 2017;35(Suppl 108(6)):119\u201323.","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"1613_CR22","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1007\/s10067-016-3187-z","volume":"35","author":"S Nanthapisal","year":"2016","unstructured":"Nanthapisal S, et al. Paediatric Beh\u00e7et\u2019s disease: a UK tertiary Centre experience. Clin Rheumatol. 2016;35(10):2509\u201316.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"1613_CR23","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12969-017-0213-x","volume":"15","author":"R Gallizzi","year":"2017","unstructured":"Gallizzi R, et al. A national cohort study on pediatric Behcet's disease: cross-sectional data from an Italian registry. Pediatr Rheumatol Online J. 2017;15(1):84.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"12","key":"1613_CR24","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1007\/s10067-011-1830-2","volume":"30","author":"YS Chang","year":"2011","unstructured":"Chang YS, Yang YH, Chiang BL. Neonatal Behcet's disease without maternal history. Clin Rheumatol. 2011;30(12):1641\u20135.","journal-title":"Clin Rheumatol"},{"key":"1613_CR25","doi-asserted-by":"crossref","unstructured":"Fain, O., et al., Neonatal Beh\u00e7et\u2019s disease. Vol. 98. 1995. 310\u2013311.","DOI":"10.1016\/S0002-9343(99)80382-9"},{"key":"1613_CR26","doi-asserted-by":"crossref","unstructured":"A Lewis, M. and B. L Priestley, Transient neonatal Beh\u00e7et\u2019s disease Vol. 61. 1986. 805\u2013806.","DOI":"10.1136\/adc.61.8.805"},{"key":"1613_CR27","unstructured":"Thivolet, J., F. Cambazard, and M. F Genvo, [Maternally-transmitted severe neonatal aphthosis]. Vol. 109. 1982. 815\u2013816."},{"key":"1613_CR28","doi-asserted-by":"crossref","unstructured":"G Fam, A., et al., Neonatal Behcet\u2019s Syndrome in an Infant of a Mother with the Disease Vol. 40. 1981. 509\u2013512.","DOI":"10.1136\/ard.40.5.509"},{"issue":"1","key":"1613_CR29","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/rheumatology\/keq324","volume":"50","author":"I Kone-Paut","year":"2011","unstructured":"Kone-Paut I, et al. Registries in rheumatological and musculoskeletal conditions. Paediatric Behcet\u2019s disease: an international cohort study of 110 patients. One-year follow-up data. Rheumatology (Oxford). 2011;50(1):184\u20138.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"1613_CR30","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/ibd.20970","volume":"16","author":"K Matsumura","year":"2010","unstructured":"Matsumura K, Nakase H, Chiba T. Efficacy of oral tacrolimus on intestinal Behcet\u2019s disease. Inflamm Bowel Dis. 2010;16(2):188\u20139.","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"1613_CR31","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1177\/039463200902200301","volume":"22","author":"G Murdaca","year":"2009","unstructured":"Murdaca G, Colombo BM, Puppo F. Anti-TNF-alpha inhibitors: a new therapeutic approach for inflammatory immune-mediated diseases: an update upon efficacy and adverse events. Int J Immunopathol Pharmacol. 2009;22(3):557\u201365.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"1","key":"1613_CR32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/intimm\/dxu102","volume":"27","author":"C Monaco","year":"2015","unstructured":"Monaco C, et al. Anti-TNF therapy: past, present and future. Int Immunol. 2015;27(1):55\u201362.","journal-title":"Int Immunol"},{"issue":"9","key":"1613_CR33","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1093\/rheumatology\/ket170","volume":"52","author":"DMC Brinkman","year":"2013","unstructured":"Brinkman DMC, et al. Treatment choices of paediatric rheumatologists for juvenile idiopathic arthritis: etanercept or adalimumab? Rheumatology. 2013;52(9):1674\u20139.","journal-title":"Rheumatology"},{"issue":"10","key":"1613_CR34","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.autrev.2010.05.017","volume":"9","author":"G Simonini","year":"2010","unstructured":"Simonini G, et al. Current therapeutic approaches to autoimmune chronic uveitis in children. Autoimmun Rev. 2010;9(10):674\u201383.","journal-title":"Autoimmun Rev"},{"issue":"4","key":"1613_CR35","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.pediatrneurol.2010.04.021","volume":"43","author":"AB Robinson","year":"2010","unstructured":"Robinson AB, Gallentine WB, Rabinovich CE. Pediatric neuro-Behcet\u2019s disease responsive to adalimumab. Pediatr Neurol. 2010;43(4):291\u20133.","journal-title":"Pediatr Neurol"},{"issue":"2","key":"1613_CR36","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1177\/039463200902200235","volume":"22","author":"L Cantarini","year":"2009","unstructured":"Cantarini L, et al. Safety and efficacy of etanercept in children with juvenile-onset Behcets disease. Int J Immunopathol Pharmacol. 2009;22(2):551\u20135.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"8","key":"1613_CR37","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1136\/bjo.2007.127522","volume":"92","author":"C Evereklioglu","year":"2008","unstructured":"Evereklioglu C, Borlu M. Sustained remission after infliximab in a child with vasculitis refractory to conventional immunosuppressives including interferon-\u03b1. Br J Ophthalmol. 2008;92(8):1034.","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"1613_CR38","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1093\/rheumatology\/kem103","volume":"46","author":"E Seyahi","year":"2007","unstructured":"Seyahi E, et al. Infliximab in the treatment of hepatic vein thrombosis (Budd-Chiari syndrome) in three patients with Beh\u00e7et\u2019s syndrome. Rheumatology. 2007;46(7):1213\u20134.","journal-title":"Rheumatology"},{"issue":"12","key":"1613_CR39","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1002\/art.40235","volume":"69","author":"PP Sfikakis","year":"2017","unstructured":"Sfikakis PP, et al. Brief report: drug-free long-term remission in severe Behcet\u2019s disease following withdrawal of successful anti-tumor necrosis factor treatment. Arthritis Rheumatol. 2017;69(12):2380\u20135.","journal-title":"Arthritis Rheumatol"},{"issue":"2\u20133","key":"1613_CR40","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s12026-013-8411-1","volume":"56","author":"F Caso","year":"2013","unstructured":"Caso F, et al. Refractory pemphigus foliaceus and Behcet\u2019s disease successfully treated with tocilizumab. Immunol Res. 2013;56(2\u20133):390\u20137.","journal-title":"Immunol Res"},{"issue":"10","key":"1613_CR41","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1093\/rheumatology\/ket130","volume":"52","author":"AP Diamantopoulos","year":"2013","unstructured":"Diamantopoulos AP, Hatemi G. Lack of efficacy of tocilizumab in mucocutaneous Behcet\u2019s syndrome: report of two cases. Rheumatology (Oxford). 2013;52(10):1923\u20134.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"1613_CR42","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.semarthrit.2015.11.012","volume":"45","author":"A Deroux","year":"2016","unstructured":"Deroux A, Chiquet C, Bouillet L. Tocilizumab in severe and refractory Behcet\u2019s disease: four cases and literature review. Semin Arthritis Rheum. 2016;45(6):733\u20137.","journal-title":"Semin Arthritis Rheum"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1613-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12887-019-1613-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1613-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T15:08:31Z","timestamp":1598540911000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-019-1613-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,11]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1613"],"URL":"https:\/\/doi.org\/10.1186\/s12887-019-1613-5","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,11]]},"assertion":[{"value":"3 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by National Taiwan University\u2019s Hospital Research Ethics Committee (IRB approval number: 201710060RINC).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"232"}}